2023 Licensing Pharmaceutical 
Penn Nursing
APRIL 27, 2021
However, near the end of the document, in Chapter 7, “Achieving Acceptance of COVID-19 Vaccine,” the authors acknowledge that “distrust in the government, in the medical research community, and in pharmaceutical companies” is a key factor in “COVID-19 vaccine hesitancy.”
Nursing Review
JULY 14, 2025
US President Donald Trump’s proposed tariffs on Australia’s pharmaceutical exports to the United States has raised alarm among industry and government leaders. More than 900 medicines were listed on the scheme in 2023–24, costing the government $17.7 Neither directly negotiates with pharmaceutical companies. billion last year.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Minority Nurse
SEPTEMBER 28, 2023
In the world of nursing, consistent rates of students graduating from nursing programs, becoming licensed, and successfully entering the workforce are critical to the long-term viability of the nursing profession and the healthcare system itself. In that regard, nursing education is a pipeline to the future.
Healthcare Law Insights blog
JANUARY 25, 2024
Psychedelics have the potential to treat chronic conditions such as post-traumatic stress disorder (PTSD), depression, obsessive-compulsive disorder (OCD), fibromyalgia, and various behavioral health conditions, yet psychedelics are not like traditional pharmaceuticals.
Health Leaders | Nursing
SEPTEMBER 25, 2023
Virtual nursing, the return of licensed practical nurses to acute care, and adding advanced practice nurses are among care models nurse executives are implementing as they seek to adapt to the current state of today’s healthcare environment. Some of our teams use EMTs while others use athletic trainers alongside physical therapists.
Health Leaders | Nursing
APRIL 10, 2023
My mantra is everyone on the team will be working to the top of their scope and that means the top of their license, their board certification, and their training, and that aligns with how we attract and engage and retain the best talent. It’s worked. We have amazing people who come to work with our organization, and they stay.
Healthcare Law Insights blog
JUNE 30, 2023
On June 23, 2023 the U.S. All comments should be identified with the docket number FDA-2023-D-1987. Food and Drug Administration (FDA) published a draft guidance document with foundational considerations for researchers that are developing psychedelic drugs for the treatment of medical conditions.
Expert insights. Personalized for you.
Let's personalize your content